Molecular Test Detects Bile Duct Cancer at Twice the Rate of Standard Methods
A molecular test developed at UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine detected bile duct cancer at roughly twice the rate of standard pathology, offering clinicians a more accurate diagnostic tool for one of oncology’s more elusive malignancies. The test, called BiliSeq, was evaluated in a prospective, multi-institutional study published … Read more